EUVIMEDEUVIMED entdecken
Multizentrische StudieKommentarOpen Access · CC BY 4.0

Prevalence of Cardiac Amyloidosis Among Elderly Patients With Recent-Onset Atrial Fibrillation: The PREVAL-ATTR Study

Paloma Remior-Pérez, Miriam Gómez-Molina, Daniel García-Rodríguez, María Gallego-Delgado, Laroussi Mohamed-Salem, Javier de Haro-Del Moral, Fernando Hernández-Terciado, Daniel de Castro, Rocio Eiros-Bachiller, Fernando Dominguez, Esther Gonzalez-Lopez, Eduardo Villacorta und 2 weitere

Canadian Journal of Cardiology · 2025

DOI: 10.1016/j.cjca.2024.10.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Canadian Journal of Cardiology, 2025. Verfasst von Paloma Remior-Pérez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain. Hauptthemen laut MEDLINE: Atrial Fibrillation, Amyloid Neuropathies, Familial, Cardiomyopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transthyretin cardiac amyloidosis (ATTR-CA) is increasingly recognized as a treatable form of heart failure. Atrial fibrillation (AF) is common in patients with ATTR-CA. Whether recent-onset AF can be used as an early marker to identify patients with ATTR-CA has not been elucidated. METHODS: This was a prospective study conducted at 3 Spanish centres. ATTR-CA noninvasive screening was offered to patients ≥ 65 years of age recently diagnosed (< 1 year) with nonvalvular AF and who had ≥ 1 echocardiographic, electrocardiographic, or clinical sign suggestive of ATTR-CA. RESULTS: A total of 121 patients were included (75% male, mean age 77 ± 7 years). Ten patients (8.3%; 95% confidence interval [CI],4-14.7%), were diagnosed with cardiac amyloidosis (CA): 5 with definite wild-type ATTR-CA (ATTRwt), 4 with likely ATTRwt, and 1 with undetermined CA. Compared with patients without CA, patients with CA were older (84 ± 4 vs 76 ± 7 years; P < 0.001), more frequently men (90% vs 59%; P = 0.047), presented higher median N-terminal pro-B-type natriuretic peptide (NTproBNP) (3800 pg/L, interquartile range [IQR]:1682-6101 vs 1048 pg/mL, IQR: 427-3154; P = 0.017) and higher left ventricular hypertrophy (LVH) (14 mm, IQR: 13-17 vs 12 mm, IQR: 12-13; P = 0.003). Patients with CA also showed higher rate of permanent AF (90% vs 49.5%; P = 0.018) and a greater need for pacemaker implantation during follow-up (30% vs 7.3%; P = 0.049). No differences in mortality were observed between patients with and without CA after a median follow-up of 13 months (IQR: 11-16 months). CONCLUSIONS: Routine DPD scanning in elderly patients with recent-onset AF, LVH and an additional red flag may help to identify patients with ATTR-CA. However, larger studies evaluating this strategy in more diverse clinical settings would be required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAmyloid Neuropathies, FamilialCardiomyopathiesHumansMaleFemaleAgedProspective StudiesPrevalenceSpainAged, 80 and overEchocardiographyElectrocardiography

Autor:innen und Institutionen

  • Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
  • Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • CIBERCV, Instituto de Salud Carlos III, Madrid, Spain; Inherited Cardiac Diseases Unit, Department of Cardiology, Instituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanc…
  • Department of Nuclear Medicine, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, Madrid, Spain.
  • Inherited Cardiac Diseases Unit, Department of Cardiology, Instituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL…

Förderung

  • Pfizer

Zitieren

APA

Remior-Pérez, P., Gómez-Molina, M., García-Rodríguez, D., Gallego-Delgado, M., Mohamed-Salem, L., de Haro-Del Moral, J., Hernández-Terciado, F., de Castro, D., Eiros-Bachiller, R., Dominguez, F., Gonzalez-Lopez, E., Villacorta, E., Pascual-Figal, D. A., & Garcia-Pavia, P. (2025). Prevalence of Cardiac Amyloidosis Among Elderly Patients With Recent-Onset Atrial Fibrillation: The PREVAL-ATTR Study. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2024.10.010

Vancouver

Remior-Pérez P, Gómez-Molina M, García-Rodríguez D, Gallego-Delgado M, Mohamed-Salem L, de Haro-Del Moral J, et al. Prevalence of Cardiac Amyloidosis Among Elderly Patients With Recent-Onset Atrial Fibrillation: The PREVAL-ATTR Study. Canadian Journal of Cardiology. 2025. doi:10.1016/j.cjca.2024.10.010

BibTeX
@article{RemiorPrez2025,
  author = {Remior-Pérez, Paloma and Gómez-Molina, Miriam and García-Rodríguez, Daniel and Gallego-Delgado, María and Mohamed-Salem, Laroussi and de Haro-Del Moral, Javier and Hernández-Terciado, Fernando and de Castro, Daniel and Eiros-Bachiller, Rocio and Dominguez, Fernando and Gonzalez-Lopez, Esther and Villacorta, Eduardo and Pascual-Figal, Domingo A and Garcia-Pavia, Pablo},
  title = {Prevalence of Cardiac Amyloidosis Among Elderly Patients With Recent-Onset Atrial Fibrillation: The PREVAL-ATTR Study},
  journal = {Canadian Journal of Cardiology},
  year = {2025},
  doi = {10.1016/j.cjca.2024.10.010}
}
Kostenlos starten →